Patni Rajiv Insider Trades

Insider Trading History

Track insider trading activity for Patni Rajiv. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Director
Holding Value $19.7k 17,000 shares
Last Trade
Jan 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34.2k 17,000 shares
$2.01
$1.16
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $27.8k 27,000 shares
Last Trade
Jun 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$29.4k 27,000 shares
$1.09
$1.03
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Director
Holding Value $51k 44,000 shares
Last Trade
Jan 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$244k 44,000 shares
$5.54
$1.16
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Director
Holding Value $0 0 shares
Last Trade
Jan 15, 2025 Sale
$83.1k 15,000 shares
$5.54
$1.16
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $13.9k 13,500 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.1k 13,500 shares
$0.82
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $55.6k 54,000 shares
Last Trade
Feb 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$70.2k 54,000 shares
$1.30
$1.03
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Evp, Chief R&d Officer
Holding Value $0 0 shares
Last Trade
Sep 26, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$23.3M 135,000 shares
$172.36
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Evp, Chief R&d Officer
Holding Value $15.5M 90,000 shares
Last Trade
Jun 12, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.4M 135,000 shares
$99.12
$172.36
Portola Pharmaceuticals
Portola Pharmaceuticals PTLA
Evp, CMO
Holding Value $0 0 shares
Last Trade
Jul 02, 2020 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
No data
No data
$0.00
Adamas Pharmaceuticals
Adamas Pharmaceuticals ADMS
Chief Medical Officer
Holding Value $404k 49,141 shares
Last Trade
Apr 08, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$409k 60,000 shares
$6.81
$8.22
Adamas Pharmaceuticals
Adamas Pharmaceuticals ADMS
Chief Medical Officer
Holding Value $157k 19,141 shares
Last Trade
Mar 20, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$19k 2,374 shares
$8.01
$8.22
Adamas Pharmaceuticals
Adamas Pharmaceuticals ADMS
Chief Medical Officer
Holding Value $177k 21,515 shares
Last Trade
Mar 21, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$32.5k 1,252 shares
$25.94
$8.22
Adamas Pharmaceuticals
Adamas Pharmaceuticals ADMS
Chief Medical Officer
Holding Value $177k 21,515 shares
Last Trade
Mar 21, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$32.5k 1,252 shares
$25.94
$8.22
Adamas Pharmaceuticals
Adamas Pharmaceuticals ADMS
Chief Medical Officer
Holding Value $450k 54,750 shares
Last Trade
Mar 06, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.4M 54,750 shares
$25.66
$8.22
Adamas Pharmaceuticals
Adamas Pharmaceuticals ADMS
Chief Medical Officer
Holding Value $112k 13,642 shares
Last Trade
Mar 21, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
$12.5k 733 shares
$17.04
$8.22
Adamas Pharmaceuticals
Adamas Pharmaceuticals ADMS
Chief Medical Officer
Holding Value $339k 41,250 shares
Last Trade
Jan 18, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$685k 41,250 shares
$16.61
$8.22
Adamas Pharmaceuticals
Adamas Pharmaceuticals ADMS
Chief Medical Officer
Holding Value $370k 45,000 shares
Last Trade
Mar 04, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$717k 52,500 shares
$13.66
$8.22
Adamas Pharmaceuticals
Adamas Pharmaceuticals ADMS
Chief Medical Officer
Holding Value $986k 120,000 shares
Last Trade
Jun 08, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.3M 120,000 shares
$19.14
$8.22

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up